• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    United Therapeutic (NQ: UTHR )

    329.16 +0.49 (+0.15%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 300,407
    Open 328.91
    Bid (Size) 328.85 (13)
    Ask (Size) 329.16 (4)
    Prev. Close 328.67
    Today's Range 326.49 - 331.73
    52wk Range 208.62 - 339.56
    Shares Outstanding 44,891,523
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Biotech Arvinas Stock Earns 82 RS Rating
    The Relative Strength (RS) Rating for Arvinas stock entered a new percentile Wednesday, with a rise from 62 to 82. 
    Via Investor's Business Daily
    Don't overlook NASDAQ:UTHR—it's a hidden gem with strong fundamentals and an attractive price tag.
    Despite its impressive fundamentals, UNITED THERAPEUTICS CORP (NASDAQ:UTHR) remains undervalued. 
    Via Chartmill

    Performance

    YTD
    +44.78%
    +44.78%
    1 Month
    +6.53%
    +6.53%
    3 Month
    +38.34%
    +38.34%
    6 Month
    +51.10%
    +51.10%
    1 Year
    +34.71%
    +34.71%

    More News

    Read More
    Denali Therapeutics Stock Gets Technical Rating Upgrade
    Via Investor's Business Daily
    If You Invested $1000 In This Stock 20 Years Ago, You Would Have $28,000 Today
    Via Benzinga
    3 Biotech Stocks to Buy Now: Q3 Edition
    Via InvestorPlace
    United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary Fibrosis
    From United Therapeutics Corporation
    Via Business Wire
    Unveiling 6 Analyst Insights On United Therapeutics
    Via Benzinga
    Deep Dive Into United Therapeutics Stock: Analyst Perspectives (5 Ratings)
    Via Benzinga
    3 Undervalued Stocks on Track to Double (or More) by 2028
    Via InvestorPlace
    Members of Congress Buy and Sell Stocks. These ETFs Let You Invest Like Democrats or Republicans.
    Via The Motley Fool
    Topics ETFs
    7 Undervalued Biotech Stocks to Buy for Big-Time Returns
    Via InvestorPlace
    Chart Of The Day: United Therapeutics - Drugs For Chronic Illnesses
    Via Talk Markets
    UroGen Pharma Stock Earns 91 RS Rating
    Via Investor's Business Daily
    United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of Directors
    From United Therapeutics Corporation
    Via Business Wire
    When you look at NASDAQ:UTHR, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
    Via Chartmill
    Arcellx Stock Earns Relative Strength Rating Upgrade
    Via Investor's Business Daily
    The 3 Best Medical Device Stocks to Buy in June 2024
    Via InvestorPlace
    Intra-Cellular Therapies Stock Scores RS Rating Upgrade To 87
    Via Investor's Business Daily
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Neurocrine Biosciences Stock Tops Milestone Amid New Drug Plans
    Via Investor's Business Daily
    Madrigal Pharmaceuticals Stock Earns RS Rating Upgrade
    Via Investor's Business Daily
    Krystal Biotech Stock Sees RS Rating Jump To 91
    Via Investor's Business Daily
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Halozyme Therapeutics Scores RS Rating Jump To 91
    Via Investor's Business Daily
    For those who appreciate value investing, NASDAQ:UTHR is a compelling option with its solid fundamentals.
    Via Chartmill
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.